Saving Sight: New Developments in Treating Retinal Diseases at Massachusetts General Brigham

CME/CE

Jointly provided by Partners for Advancing Clinical Education (PACE) and DKBmed, LLC.

Launch Date: 12/20/24 

Expiration Date: 12/19/25 

Acknowledgement

This activity is supported by an independent medical education grant Regeneron Pharmaceuticals, Inc. 

Target Audience

This activity is intended for ophthalmologists in Massachusetts and across the country, including retina specialists.

Educational Objectives

Upon completion of this activity, participants should be able to:  

  • Discuss how we can improve screening and prevent delayed treatment in both diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). ​ 
  • Discuss consequences of delayed treatment initiation for patients with DME and nAMD.​ 
  • Describe efficacy and safety of newer anti-VEGF treatments for nAMD to increase treatment adherence. ​ 
  • Evaluate the benefits of newly available treatment anti-VEGF options for DME.  

Faculty and Disclosure of Conflicts of Interest Faculty Conflicts of Interest

Faculty Conflicts of Interest
Grayson Armstrong, MD, MPH
Director, Ophthalmology Emergency Services
Massachusetts Eye & Ear
Harvard Medical School 		Consultant, Advisor, Speaker: Ocular Technologies, Inc., McKinsey & Company, Kriya Therapeutics, Xenon Opthalmics, Chart Biopsy, Dynamed, Genentech
Nimish Patel, MD
Director of Pediatrics Retina, Mass. Eye and Mass. General Hospital
Director of Pediatrics Retina Surgery
Boston Children’s Hospital
Assistant Professor of Ophthalmology,
Harvard Medical School 		Consultant, Advisor, Speaker: Apellis, Allergan, Biogen, Alimera, Eyepoint Pharmaceuticals, Genentech, Regeneron
Researcher: Kyoto, Regenx Bio

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships. 

Fee Information

There is no fee for this educational activity.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and DKBmed, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Hardware & Software Requirements

To access activities, users will need:

  • A computer with an internet connection 
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher) 

Contact Information

For additional information about the accreditation of this activity, please visit https://partnersed.com